We investigated the prognostic significance of the presence or absence of vertigo and tinnitus, the timing of the initiation of treatment, the type and severity of hearing loss, and age in 72 patients who had experienced sudden hearing loss. We found that the factors associated with a positive prognosis were the absence of vertigo, the presence of tinnitus, initiation of treatment within 7 days, a greater degree of hearing loss in the low frequencies, and a hearing loss of less than 45 dB. Age had no effect on prognosis.
References
1.
EisenmanD., ArtsH.A.Effectiveness of treatment for sudden sensorineural hearing loss. Arch Otolaryngol Head Neck Surg2000; 126: 1161–4.
2.
BylF.M.Seventy-six cases of presumed sudden hearing loss occurring in 1973: Prognosis and incidence. Laryngoscope1977; 87: 817–25.
KallinenJ., LaurikainenE., LaippalaP., GrenmanR.Sudden deafness: A comparison of anticoagulant therapy and carbogen inhalation therapy. Ann Otol Rhinol Laryngol1997; 106: 22–6.
NomuraY.Diagnostic criteria for sudden deafness, mumps deafness and perilymphatic fistula. Acta Otolaryngol Suppl1988; 456: 7–8.
8.
MoskowitzD., LeeK.J., SmithH.W.Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope1984; 94: 664–6.
9.
SaekiN., KitaharaM.Assessment of prognosis in sudden deafness. Acta Otolaryngol Suppl1994; 510: 56–61.
10.
ShaiaF.T., SheehyJ.L.Sudden sensori-neural hearing impairment: A report of 1,220 cases. Laryngoscope1976; 86: 389–98.
11.
EinerH., TengbornL., AxelssonA., EdstromS.Sudden sensorineural hearing loss and hemostatic mechanisms. Arch Otolaryngol Head Neck Surg1994; 120: 536–40.
12.
ShikowitzM.J.Sudden sensorineural hearing loss. Med Clin North Am1991; 75: 1239–50.
13.
HarrisJ.P., RuckensteinM.J.Sudden sensorineural hearing loss, perilymph fistula and autoimmune inner ear disease. In: BallengerJ.J., SnowJ.B.Jr., eds. Otorhinolaryngology: Head and Neck Surgery.Baltimore: Williams & Wilkins, 1996: 1109–18.
14.
ShiraishiT., KuboT., OkumuraS.Hearing recovery in sudden deafness patients using a modified defibrinogenation therapy. Acta Otolaryngol Suppl1993; 501: 46–50.
15.
MegighianD., BolzanM., BarionU., NicolaiP.Epidemiological considerations in sudden hearing loss: A study of 183 cases. Arch Otorhinolaryngol1986; 243: 250–3.
KronenbergJ., AlmagorM., BendetE., KushnirD.Vasoactive therapy versus placebo in the treatment of sudden hearing loss: A double-blind clinical study. Laryngoscope1992; 102: 65–8.
MenottiA., KromhoutD., BlackburnH.Food intake patterns and 25-year mortality from coronary heart disease: Cross-cultural correlations in the Seven Countries Study. The Seven Countries Study Research Group. Eur J Epidemiol1999; 15: 507–15.
